Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antecip Bioventures Ii LlcfiledCriticalAntecip Bioventures Ii Llc
Priority to MYPI2021001960ApriorityCriticalpatent/MY196155A/en
Publication of MY196155ApublicationCriticalpatent/MY196155A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as Modic changes type I.
MYPI2021001960A2015-05-272015-05-27Osteoclast Inhibitors for Pain
MY196155A
(en)